The non-vitamin compounds (MIC) that are injected into the body stimulate the liver into optimizing the process of metabolism, elevate the movement of and utilization of fat, and provide the needed metabolic environment of the body for a fatty acid (fat) mobilization and utilization
These latter symptoms are the most easily recognized because they cause skin spots, bleeding of gums, and loose teeth, as well as bone and cartilage fragility
The obesity drugs sector is marked by fierce competition and relentless innovation, as companies seek to maximize efficacy and differentiate their offerings
At the individual level, obesity has been linked to poor health outcomes and is associated with comorbidities including type 2 diabetes, cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease
Wang L, Huang W, Zhang L, Chen Q, Zhao H